Consult a physician before using this product, especially if you have a medical condition or are taking medication
Phase II clinical trials for inflammatory bowel disease reported no toxicity or adverse events in treated patients, though detailed safety data from these trials have not been published in peer-reviewed literature
Ivashko-Pachima Y, Hadar A, Grigg I, Korenkov V, Kapitansky O, Karmon G, et al
Esse aumento ser responsvel por maior oxigenao do sangue e envio de nutrientes para as clulas musculares, acarretando na regenerao das fibras depois dos treinos, resultando com isso, o ganho de massa muscular
Medical supervision: required
Retrieved 25 April 2023